CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 245 enrolled
Drug / intervention
PFNA-Asiadevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00873548
NCT00873548N/ACompleted
CompareCT.gov

Treatment of Unstable Trochanteric Fractures With the Proximal Femoral Nail - Antirotation Asia - A Prospective Multicenter Case Series

AO Clinical Investigation and Publishing Documentation·observational·Posted Apr 1, 2009·Updated Jul 22, 2021

In Brief

An observational study evaluating PFNA-Asia for Trochanteric Fractures. Completed, enrolled 245 participants across 1 site.

Detailed Summary

The primary objective of this prospective multicenter study is to assess any fracture fixation complication and revision rates during the clinical use of the Proximal Femoral Nail Antirotation Asia (PFNA Asia) for the treatment of unstable trochanteric fractures.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsTrochanteric Fractures
CountriesJapan
CollaboratorsSynthes Inc.

Timeline

N/ACompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedApr 1, 2009
Enrollment StartNov 1, 2007
Primary CompletionDec 1, 2011
Study CompletionMar 1, 2012
TodayJul 2, 2026
Enrollment to primary: 4.1 yearsPosted 17.3 years ago

Interventions

PFNA-Asiadevice

The operation is performed under regional or general anesthesia and involves the following main steps: 1. Positioning of the patient 2. Definition of the CCD-angle 3. Fracture reduction 4. Determination of the nail diameter 5. Incision 6. Insertion of the device